{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T23:06:42Z","timestamp":1774480002128,"version":"3.50.1"},"reference-count":33,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,8,25]],"date-time":"2022-08-25T00:00:00Z","timestamp":1661385600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pediatr."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>The aim of this study was to determine the differences in the characteristics of <jats:italic>Mycoplasma pneumoniae<\/jats:italic> pneumonia (MPP) in children with and without asthma and in children with asthma with and without inhaled corticosteroid (ICS) therapy in order to determine the risk factors for asthma exacerbation and the effect of regular ICS therapy on children with asthma with MPP.<\/jats:p><\/jats:sec><jats:sec><jats:title>Materials and methods<\/jats:title><jats:p>Children with MPP were divided into two groups according to whether they had a history of asthma. Children with asthma were further divided into an ICS therapy group and a group without ICS therapy. The clinical characteristics, laboratory test results, and pulmonary images were compared between the children with and without asthma. Differences in the severity of acute exacerbation were compared between the children with asthma in the ICS therapy and without ICS therapy groups. Multivariable logistic regression was used to determine the risk factors for exacerbation of MPP in children with asthma.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>In children with MPP, the differences in the eosinophil counts; total immunoglobulin E (IgE), C-reactive protein, procalcitonin (PCT), and lactate dehydrogenase (LDH) levels; and fever duration, wheezing, extrapulmonary complications, oxygen saturation &amp;lt; 92%, severe pneumonia, pleural effusion, co-infection with other pathogens, and lobar pneumonia between children with and without asthma were statistically significant. Among children with asthma with MPP, those in the ICS therapy group were less likely to experience an exacerbation, and exacerbations were less severe than those in the without ICS therapy group. The multivariable logistic regression analysis showed that the ICS therapy was an independent protective factor against exacerbation.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Among children with MPP, the chance of wheezing was higher in children with asthma than in children without asthma. The ICS therapy was a protective factor against exacerbation in children with asthma with MPP.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fped.2022.908857","type":"journal-article","created":{"date-parts":[[2022,8,25]],"date-time":"2022-08-25T07:38:56Z","timestamp":1661413136000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":4,"title":["Protective effect of inhaled corticosteroid on children with asthma with Mycoplasma pneumoniae pneumonia"],"prefix":"10.3389","volume":"10","author":[{"given":"Bing","family":"Wei","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan-Hong","family":"Dang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiang-Ping","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miao","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2022,8,25]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"11729","DOI":"10.26355\/eurrev_202011_23824","article-title":"Pharmacoeconomic management of patient with severe asthma in the emergency department: retrospective multicentric and cost of illness study.","volume":"24","author":"Pugliese","year":"2020","journal-title":"Eur Rev Med Pharmacol Sci."},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.3389\/fped.2018.00196","article-title":"Measuring airway inflammation in asthmatic children.","volume":"6","author":"Tenero","year":"2018","journal-title":"Front Pediatr."},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.5334\/aogh.2416","article-title":"Pediatric asthma: a global epidemic.","volume":"85","author":"Serebrisky","year":"2019","journal-title":"Ann Glob Health."},{"key":"B4","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1007\/s00508-016-1019-4","article-title":"Diagnosis and management of asthma \u2013 statement on the 2015 GINA guidelines.","volume":"128","author":"Horak","year":"2016","journal-title":"Wien Klin Wochenschr."},{"key":"B5","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1159\/000486797","article-title":"Diagnosis and management of asthma \u2013 the Swiss guidelines.","volume":"95","author":"Rothe","year":"2018","journal-title":"Respiration."},{"key":"B6","doi-asserted-by":"publisher","first-page":"1815","DOI":"10.1016\/j.jaip.2020.01.042","article-title":"Nebulized inhaled corticosteroids in asthma treatment in children 5 years or younger: a systematic review and global expert analysis.","volume":"8","author":"Murphy","year":"2020","journal-title":"J Allergy Clin Immunol Pract."},{"key":"B7","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1056\/NEJM200008033430504","article-title":"Low-dose inhaled corticosteroids and the prevention of death from asthma.","volume":"343","author":"Suissa","year":"2000","journal-title":"N Engl J Med."},{"key":"B8","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1081\/jas-120023581","article-title":"Budesonide inhalation suspension reduces the need for emergency intervention in pediatric asthma: a named-patient case series.","volume":"40","author":"Chipps","year":"2003","journal-title":"J Asthma."},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD007524.pub4","article-title":"Increased versus stable doses of inhaled corticosteroids for exacerbations of chronic asthma in adults and children.","volume":"2016","author":"Kew","year":"2016","journal-title":"Cochrane Database Syst Rev."},{"key":"B10","first-page":"197","article-title":"Acute effect of nebulized budesonide in asthmatic children.","volume":"15","author":"Nuhoglu","year":"2005","journal-title":"J Investig Allergol Clin Immunol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1136\/adc.2009.169177","article-title":"The role of inhaled corticosteroids and montelukast in children with mild-moderate asthma results of a systematic review with meta-analysis.","volume":"95","author":"Castro-Rodriguez","year":"2010","journal-title":"Arch Dis Child."},{"key":"B12","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1111\/cea.13124","article-title":"Distinction between rhinovirus-induced acute asthma and asthma-augmented influenza infection.","volume":"48","author":"Guibas","year":"2018","journal-title":"Clin Exp Allergy."},{"key":"B13","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1080\/23744235.2017.1400176","article-title":"Clinical characteristics of children infected with enterovirus D68 in an outpatient clinic and the association with bronchial asthma.","volume":"50","author":"Itagaki","year":"2018","journal-title":"Infect Dis (Lond)."},{"key":"B14","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1016\/S2352-4642(19)30025-2","article-title":"Advances in the aetiology, management, and prevention of acute asthma attacks in children.","volume":"3","author":"Saglani","year":"2019","journal-title":"Lancet Child Adolesc Health."},{"key":"B15","doi-asserted-by":"publisher","first-page":"23","DOI":"10.4103\/ijmr.IJMR_1582_16","article-title":"Mycoplasma pneumoniae: a significant but underrated pathogen in paediatric community-acquired lower respiratory tract infections.","volume":"147","author":"Kumar","year":"2018","journal-title":"Indian J Med Res."},{"key":"B16","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1093\/cid\/ciy419","article-title":"Mycoplasma pneumoniae among children hospitalized with community-acquired pneumonia.","volume":"68","author":"Kutty","year":"2019","journal-title":"Clin Infect Dis."},{"key":"B17","doi-asserted-by":"publisher","first-page":"618","DOI":"10.3109\/02770903.2015.1116085","article-title":"Chlamydia pneumoniae, and Mycoplasma pneumoniae: are they related to severe asthma in childhood?","volume":"53","author":"Iramain","year":"2016","journal-title":"J Asthma."},{"key":"B18","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1177\/0049475518816591","article-title":"Mycoplasma pneumoniae infection and asthma in children.","volume":"49","author":"Kumar","year":"2019","journal-title":"Trop Doct."},{"key":"B19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2147\/IJGM.S15867","article-title":"Infection with Mycoplasma pneumoniae is not related to asthma control, asthma severity, and location of airway obstruction.","volume":"4","author":"Ansarin","year":"2010","journal-title":"Int J Gen Med."},{"key":"B20","doi-asserted-by":"publisher","first-page":"271","DOI":"10.3345\/kjp.2014.57.6.271","article-title":"Increased risk of refractory Mycoplasma pneumoniae pneumonia in children with atopic sensitization and asthma.","volume":"57","author":"Shin","year":"2014","journal-title":"Korean J Pediatr."},{"key":"B21","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1055\/s-0036-1584923","article-title":"Adenovirus: epidemiology, global spread of novel serotypes, and advances in treatment and prevention.","volume":"37","author":"Lynch","year":"2016","journal-title":"Semin Respir Crit Care Med."},{"key":"B22","doi-asserted-by":"crossref","first-page":"156","DOI":"10.23736\/S0026-4946.16.04866-0","article-title":"Diagnosis and treatmen of Mycoplasma pneumoniae in children.","volume":"69","author":"Rogozinski","year":"2017","journal-title":"Minerva Pediatr."},{"key":"B23","doi-asserted-by":"publisher","first-page":"1172","DOI":"10.1183\/09031936.00199913","article-title":"Classification and pharmacological treatment of preschool wheezing: changes since.","volume":"2014","author":"Brand","year":"2008","journal-title":"Eur Respir J."},{"key":"B24","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1254\/fpj.141.287","article-title":"Mycoplasma pneumoniae.","volume":"141","author":"Ubukata","year":"2013","journal-title":"Nihon Yakurigaku Zasshi."},{"key":"B25","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.1016\/j.bbrc.2018.11.132","article-title":"Production and characterization of recombinant P1 adhesin essential for adhesion, gliding, and antigenic variation in the human pathogenic bacterium, Mycoplasma pneumoniae.","volume":"508","author":"Kenri","year":"2019","journal-title":"Biochem Biophys Res Commun."},{"key":"B26","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1111\/j.1365-2958.2010.07092.x","article-title":"Mycoplasma pneumoniae community acquired respiratory distress syndrome toxin expression reveals growth phase and infection-dependent regulation.","volume":"76","author":"Kannan","year":"2010","journal-title":"Mol Microbiol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1080\/02770903.2019.1628254","article-title":"Advantage of inhaled corticosteroids as additional therapy to systemic corticosteroids for pediatric acute asthma exacerbations: a cost-effectiveness analysis.","volume":"57","author":"Rodriguez-Martinez","year":"2020","journal-title":"J Asthma."},{"key":"B28","doi-asserted-by":"publisher","first-page":"366","DOI":"10.5863\/1551-6776-27.4.366","article-title":"Risk factors and outcomes associated with antibiotic therapy in children hospitalized with asthma exacerbation.","volume":"27","author":"Pinto","year":"2022","journal-title":"J Pediatr Pharmacol Ther."},{"key":"B29","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1165\/rcmb.2017-0002OC","article-title":"A multiomics approach to identify genes associated with childhood asthma risk and morbidity.","volume":"57","author":"Forno","year":"2017","journal-title":"Am J Respir Cell Mol Biol."},{"key":"B30","first-page":"S1041","article-title":"Risk factors of relapse within eight weeks after an acute asthma exacerbation in Thai children.","author":"Benjaponpitak","year":"2002","journal-title":"J Med Assoc Thai."},{"key":"B31","doi-asserted-by":"publisher","first-page":"3702","DOI":"10.3760\/cma.j.ch112137-20200408-01125","article-title":"Evaluation of the efficacy of Chinese children\u2019s asthma action plan on the long-term management of children with asthma at home.","volume":"100","author":"Zhang","year":"2020","journal-title":"Zhonghua Yi Xue Za Zhi."},{"key":"B32","doi-asserted-by":"publisher","first-page":"161","DOI":"10.4103\/JETS.JETS_116_19","article-title":"Role of inhaled corticosteroids for asthma exacerbation in children: an updated meta-analysis.","volume":"13","author":"Sawanyawisuth","year":"2020","journal-title":"J Emerg Trauma Shock."},{"key":"B33","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1007\/s41030-018-0061-y","article-title":"Home management of childhood asthma exacerbations.","volume":"4","author":"Yeung","year":"2018","journal-title":"Pulm Ther."}],"container-title":["Frontiers in Pediatrics"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2022.908857\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,25]],"date-time":"2022-08-25T07:39:01Z","timestamp":1661413141000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2022.908857\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,25]]},"references-count":33,"alternative-id":["10.3389\/fped.2022.908857"],"URL":"https:\/\/doi.org\/10.3389\/fped.2022.908857","relation":{},"ISSN":["2296-2360"],"issn-type":[{"value":"2296-2360","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,25]]},"article-number":"908857"}}